Duin Duin

Dr. Duin Duin


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2018 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
FFF. Fontanella
F. Fontanella
LML. Maggio
L. Maggio
JVJ. B. G. M. Verheij
J. B. G. M. Verheij
DDDuin Duin
Duin Duin
PSP. N. Adama Van Scheltema
P. N. Adama Van Scheltema
CBC. M. Bilardo
C. M. Bilardo
Objective: Fetal megacystis presents a challenge in terms of counseling and management because of its varied etiology and evolution. The aim of this study was to present a comprehensive overview of the underlying etiologies and structural anomalies associated with fetal megacystis.Methods: This was a retrospective multicenter study of cases referred to the fetal medicine unit of one of the eight academic hospitals in The Netherlands with a diagnosis of fetal megacystis. For each case, data on and measurements of fetal urinary tract and associated structural anomalies were collected. All available postmortem examinations and postnatal investigations were reviewed in order to establish the final diagnosis. In the first trimester, fetal megacystis was defined as longitudinal bladder diameter (LBD) ≥ 7 mm, and in the second and third trimesters as an enlarged bladder failing to empty during an extended ultrasound examination lasting at least 40 min.Results: Of the 541 pregnancies with fetal megacystis, it was isolated (or solely accompanied by other signs of lower urinary tract obstruction (LUTO)) in 360 (67%) cases and associated with other abnormal ultrasound findings in 181 (33%) cases. The most common associated ultrasound anomaly was an increased nuchal translucency thickness (22%), followed by single umbilical artery (10%) and cardiac defect (10%). A final diagnosis was established in 418 cases, including 222 (53%) cases with isolated LUTO and 60 (14%) infants with normal micturition or minor isolated urological anomalies. In the remaining 136 (33%) cases, concomitant developmental or chromosomal abnormality or genetic syndrome was diagnosed. Overall, 40 chromosomal abnormalities were diagnosed, including trisomy 18 (n = 24), trisomy 21 (n = 5), Turner syndrome (n = 5), trisomy 13 (n = 3) and 22q11 deletion (n = 3). Thirty‐two cases presented with anorectal malformations involving the anus, rectum and urogenital tract. In cases with confirmed urethral and anal atresia, megacystis occurred early in pregnancy and the bladder appeared severely distended (the LBD (in mm) was equal to or greater than twice the gestational age (in weeks)). Fetal macrosomia was detected in six cases and an overgrowth syndrome was detected in four cases, comprising two infants with Beckwith–Wiedemann syndrome and two with Sotos syndrome. Megacystis‐microcolon‐intestinal hypoperistalsis syndrome was diagnosed in five (1%) cases and prenatally suspected only in one case.Conclusions: Although the main cause of fetal megacystis is LUTO, an enlarged fetal bladder can also be present as a concomitant finding of miscellaneous genetic syndromes, developmental disturbances and chromosomal abnormalities. We provide an overview of the structural anomalies and congenital disorders associated with fetal megacystis and propose a practical guide for the differential diagnosis of genetic syndromes and chromosomal and developmental abnormalities in pregnancies presenting with fetal megacystis, focusing on the morphological examination of the fetus. © 2018 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.

2 April 2019 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
FFF. Fontanella
F. Fontanella
PSP. N. Adama van Scheltema
P. N. Adama van Scheltema
DDDuin Duin
Duin Duin
TCT. E. Cohen‐Overbeek
T. E. Cohen‐Overbeek
EPE. Pajkrt
E. Pajkrt
CBC. M. Bilardo
C. M. Bilardo

6 July 2020 in Prenatal Diagnosis
Verified
Journal Article
Open access
PDF file
NCNicole Corsten-Janssen
Nicole Corsten-Janssen
KBKatelijne Bouman
Katelijne Bouman
JDJanouk C. D. Diphoorn
Janouk C. D. Diphoorn
ASArjen J. Scheper
Arjen J. Scheper
RKRianne Kinds
Rianne Kinds
CDCleo C. van Diemen
Cleo C. van Diemen
Objective: Conventional genetic tests (quantitative fluorescent‐PCR [QF‐PCR] and single nucleotide polymorphism‐array) only diagnose ~40% of fetuses showing ultrasound abnormalities. Rapid exome sequencing (rES) may improve this diagnostic yield, but includes challenges such as uncertainties in fetal phenotyping, variant interpretation, incidental unsolicited findings, and rapid turnaround times. In this study, we implemented rES in prenatal care to increase diagnostic yield.Methods: We prospectively studied 55 fetuses. Inclusion criteria were: (a) two or more independent major fetal anomalies, (b) hydrops fetalis or bilateral renal cysts alone, or (c) one major fetal anomaly and a first‐degree relative with the same anomaly. In addition to conventional genetic tests, we performed trio rES analysis using a custom virtual gene panel of ~3850 Online Mendelian Inheritance in Man (OMIM) genes.Results: We established a genetic rES‐based diagnosis in 8 out of 23 fetuses (35%) without QF‐PCR or array abnormalities. Diagnoses included MIRAGE (SAMD9), Zellweger (PEX1), Walker‐Warburg (POMGNT1), Noonan (PTNP11), Kabuki (KMT2D), and CHARGE (CHD7) syndrome and two cases of Osteogenesis Imperfecta type 2 (COL1A1). In six cases, rES diagnosis aided perinatal management. The median turnaround time was 14 (range 8‐20) days.Conclusion: Implementing rES as a routine test in the prenatal setting is challenging but technically feasible, with a promising diagnostic yield and significant clinical relevance.

16 April 2021 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
FFF. Fontanella
F. Fontanella
HGH. Groen
H. Groen
DDDuin Duin
Duin Duin
SSS. Suresh
S. Suresh
CBC. M. Bilardo
C. M. Bilardo
Objective: To construct reference values for fetal urinary bladder distension in pregnancy and use Z‐scores as a diagnostic tool to differentiate posterior urethral valves (PUV) from urethral atresia (UA).Methods: This was a prospective cross‐sectional study in healthy singleton pregnancies aimed at constructing nomograms of fetal urinary bladder diameter and volume between 15 and 35 weeks' gestation. Z‐scores of longitudinal bladder diameter (LBD) were calculated and validated in a cohort of fetuses with megacystis with ascertained postnatal or postmortem diagnosis, collected from a retrospective, multicenter study. Correlations between anatomopathological findings, based on medical examination of the infant or postmortem examination, and fetal megacystis were established. The accuracy of the Z‐scores was evaluated by receiver‐operating‐characteristics (ROC)‐curve analysis.Results: Nomograms of fetal urinary bladder diameter and volume were produced from three‐dimensional ultrasound volumes in 225 pregnant women between 15 and 35 weeks of gestation. A total of 1238 urinary bladder measurements were obtained. Z‐scores, derived from the fetal nomograms, were calculated in 106 cases with suspected lower urinary tract obstruction (LUTO), including 76 (72%) cases with PUV, 22 (21%) cases with UA, four (4%) cases with urethral stenosis and four (4%) cases with megacystis‐microcolon‐intestinal hypoperistalsis syndrome. Fetuses with PUV showed a significantly lower LBD Z‐score compared to those with UA (3.95 vs 8.83, P < 0.01). On ROC‐curve analysis, we identified 5.2 as the optimal Z‐score cut‐off to differentiate fetuses with PUV from the rest of the study population (area under the curve, 0.84 (95% CI, 0.748–0.936); P < 0.01; sensitivity, 74%; specificity, 86%).Conclusions: Z‐scores of LBD can distinguish reliably fetuses with LUTO caused by PUV from those with other subtypes of LUTO, with an optimal cut‐off of 5.2. This information should be useful for prenatal counseling and management of LUTO. © 2021 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

28 October 2019 in Prenatal Diagnosis
Verified
Journal Article
Closed access
PDF file
DDDuin Duin
Duin Duin
FFFederica Fontanella
Federica Fontanella
HGHenk Groen
Henk Groen
PSPhebe N. Adama van Scheltema
Phebe N. Adama van Scheltema
TCTitia E. Cohen‐Overbeek
Titia E. Cohen‐Overbeek
CBCaterina M. Bilardo
Caterina M. Bilardo

6 February 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
EBEddy de Boer
Eddy de Boer
NCNicole Corsten-Janssen
Nicole Corsten-Janssen
EWElles Wierenga
Elles Wierenga
TBTheo Bijma
Theo Bijma
JKJurjen Knapper
Jurjen Knapper
CDCleo C. van diemen
Cleo C. van diemen
Background: In prenatal genetic diagnostics, the detection of single-gene defects relies on chorionic villus sampling (CVS) and amniocentesis, which carry a miscarriage risk of 0.2–0.3%. To mitigate this risk, fetal trophoblasts have been isolated from a Papanicolaou smear using Trophoblast Retrieval and Isolation from the Cervix (TRIC). However, this method is labor-intensive and has been shown to be challenging to implement in clinical practice. Here, we describe our experiences in using semi-automated immunomagnetic cell sorting for isolating trophoblasts from clinically obtained Papanicolaou smears during ongoing pregnancies. Methods: Using HLA-G-positive Jeg-3 and HLA-G-negative HeLa cell lines in 10%, 1%, and 0.1% dilutions, we tested and optimized the isolation of HLA-G-positive cells using FACS and semi-automated immunomagnetic cell sorting. We used the latter technique for isolation of HLA-G-positive cells from Papanicolaou smears collected from 26 pregnant women, gestational age between 6 and 20 weeks, who underwent CVS. Results: In four independent dilution series, the mean percentages of Jeg-3 cells went from 7.1% to 53.5%, 0.9% to 32.6%, and 0.4% to 2.6% (7.5, 36, and 6.5-fold enrichment, respectively) using immunomagnetic cell sorting. After sorting of the Papanicolaou smears, HLA-G-positive cells were moderately increased in the positive (14.61 vs. 11.63%) and decreased in the negative fraction (7.87 vs. 11.63%) compared to baseline pre-sorting. However, we could not identify fetal cells using XY-chromosomal FISH in a male sample. Conclusions: Our study supports previous findings that careful sampling of fetal cells from Papanicolaou smears in a clinical context poses significant challenges to cell retrieval.